LXRα Inhibitors

Common LXRα Inhibitors include, but are not limited to GW 3965 hydrochloride CAS 405911-17-3, T 0901317 CAS 293754-55-9, Trihydroxycoprostane CAS 547-96-6, Bexarotene CAS 153559-49-0 and GW 3965 hydrochloride CAS 405911-17-3.

LXRα inhibitors belong to a chemical class of compounds designed to target and inhibit the activity of liver X receptor alpha (LXRα). LXRα is a nuclear receptor that plays a key role in the regulation of cholesterol and lipid metabolism. It functions as a transcription factor, modulating the expression of genes involved in cholesterol homeostasis, lipid synthesis, and transport. LXRα forms heterodimers with the retinoid X receptor (RXR) and binds to specific DNA sequences known as LXR response elements (LXREs) within target gene promoters.

The inhibition of LXRα activity by these compounds aims to modulate the transcriptional regulation of LXR target genes, thereby influencing cellular lipid balance and metabolism. LXRα inhibitors are designed to interact with LXRα and disrupt its interaction with coactivator proteins, thereby preventing its activation and subsequent gene expression. By targeting LXRα, these inhibitors provide a means to explore the complex regulatory network underlying lipid metabolism and cholesterol homeostasis. Research into LXRα inhibitors contributes to a deeper understanding of the molecular mechanisms involved in maintaining lipid equilibrium and offers insights into strategies for manipulating these processes at the cellular level.